Future directions of imaging MS in pharmaceutical R&D

Bioanalysis

Volumn 7, Issue 20, 2015, Pages 2667-2673

  Goodwin, Richard J A ^a   Webborn, Peter JH ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

MS imaging; MS profiling; rastering

Indexed keywords

ARTICLE; CHEMICAL ANALYSIS; DRUG DESIGN; DRUG DETERMINATION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; IMAGE QUALITY; IONIZATION; MASS SPECTROMETER; MASS SPECTROMETRY; MASS SPECTROMETRY IMAGING; NONHUMAN; SAMPLING; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; CHEMISTRY; METABOLISM; RESEARCH; TRENDS;

DRUG;

DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; RESEARCH; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84946842742     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.15.156     Document Type: Article

References (43)

1. Rowland M, Peck C, Tucker G. Physiologically-based pharmacokinetics in drug development and regulatory science. Ann. Rev. Pharm. Toxicol. 51(1), 45-73 (2011
2. Ballard P, Brassil P, Bui KH, et al. The right compound in the right assay at the right time: an integrated discovery DMPK strategy. Drug Metabol. Rev. 44(3), 224-252 (2012
3. Prideaux B, Stoeckli M. Mass spectrometry imaging for drug distribution studies. J. Proteomics 75(16), 4999-5013 (2012
4. Schober Y, Guenther S, Spengler B, Römpp A. Single cell matrix-assisted laser desorption/ionization mass spectrometry imaging. Anal. Chem. 84(15), 6293-6297 (2012
5. Zavalin A, Todd EM, Rawhouser PD, Yang J, Norris JL, Caprioli RM. Direct imaging of single cells and tissue at sub-cellular spatial resolution using transmission geometry MALDI MS. J. Mass Spectrom. 47(11), 1473-1481 (2012
6. Kawashima M, Iwamoto N, Kawaguchi-Sakita N, et al. High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci. 104(10), 1372-1379 (2013
7. Eikel D, Vavrek M, Smith S, et al. Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example. Rapid Commun. Mass Spectrom. 25(23), 3587-3596 (2011
8. Blatherwick EQ, Van Berkel GJ, Pickup K, et al. Utility of spatially-resolved atmospheric pressure surface sampling and ionization techniques as alternatives to mass spectrometric imaging (MSI) in drug metabolism. Xenobiotica 41(8), 720-734 (2011
9. Nilsson A, Fehniger TE, Gustavsson L, et al. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS ONE 5(7), e11411 (2010
10. Hamm G, Bonnel D, Legouffe R, et al. Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor. J. Proteomics 75(16), 4952-4961 (2012
11. Källback P, Shariatgorji M, Nilsson A, Andrén PE. Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J. Proteomics 75(16), 4941-4951 (2012
12. Goodwin RJ, Lang AM, Allingham H, Borén M, Pitt AR. Stopping the clock on proteomic degradation by heat treatment at the point of tissue excision. Proteomics 10(9), 1751-1761 (2010
13. Goodwin RJ, Pitt AR. Mass spectrometry imaging of pharmacological compounds in tissue sections. Bioanalysis 2(2), 279-293 (2010
14. Blatherwick EQ, Svensson CI, Frenguelli BG, Scrivens JH. Localisation of adenine nucleotides in heat-stabilised mouse brains using ion mobility enabled MALDI imaging. Int. J. Mass Spectrom. 345-347, 19-27 (2013
15. Shariatgorji M, Källback P, Gustavsson L, et al. ControlledpH tissue cleanup protocol for signal enhancement of small molecule drugs analyzed by MALDI-MS imaging. Anal. Chem. 84(10), 4603-4607 (2012
16. Djidja M-C, Francese S, Loadman PM, et al. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalinfixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 9(10), 2750-2763 (2009
17. Franck J, Ayed M, Wisztorski M, Salzet M, Fournier I. On tissue protein identification improvement by n-terminal peptide derivatization. In: Mass Spectrometry Imaging. Rubakhin SS, Sweedler JV (Eds). Humana Press, Totowa, NJ, USA, 323-338 (2010
18. Jaskolla TW, Lehmann W-D, Karas M. 4-chloro-α-cyanocinnamic acid is an advanced, rationally designed MALDI matrix. Proc. Natl. Acad. Sci. USA 105(34), 12200-12205 (2008
19. Shariatgorji M, Nilsson A, Goodwin RJ, et al. Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules. Anal. Chem. 84(16), 7152-7157 (2012
20. Manier ML, Reyzer M, Goh A, et al. Reagent precoated targets for rapid in-tissue derivatization of the antituberculosis drug isoniazid followed by MALDI imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 22(8), 1409-1419 (2011
21. Cobice DF, Mackay CL, Goodwin RJ, et al. Mass spectrometry imaging for dissecting steroid intracrinology within target tissues. Anal. Chem. 85(23), 11576-11584 (2013
22. Stauber J, Ayed M, Wisztorski M, Salzet M, Fournier I. Specific MALDI-MSI: TAG-MASS. In: Mass Spectrometry Imaging. Rubakhin SS, Sweedler JV (Eds). Humana Press, Totowa, NJ, USA, 339-361 (2010
23. Wisztorski M, Lemaire R, Stauber J, et al. Imagerie MALDI. Med. Sci. (Paris) 23, 31-38 (2007
24. Nilsson A, Forngren B, Bjurström S, et al. In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studies. PLoS ONE 7(10), e47353 (2012
25. Visser SA, Aurell M, Jones RD, et al. Model-based drug discovery: implementation and impact. Drug Discov. Today 18(15-16), 764-775 (2013
26. Balog J, Sasi-Szabó L, Kinross J, et al. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci. Transl. Med. 5(194), 194ra193 (2013
27. Pickart MA, Klee EW. Zebrafish approaches enhance the translational research tackle box. Transl. Res. 163(2), 65-78 (2013
28. Liu X, Weaver EM, Hummon AB. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry. Anal. Chem. 85(13), 6295-6302 (2013
29. Chughtai K, Jiang L, Greenwood TR, Glunde K, Heeren RM. Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models. J. Lipid Res. 54(2), 333-344 (2013
30. Chughtai K, Jiang L, Post H, et al. Mass spectrometric imaging of red fluorescent protein in breast tumor xenografts. J. Am. Soc. Mass Spectrom. 24(5), 711-717 (2013
31. Stauber J, Macaleese L, Franck J, et al. On-tissue protein identification and imaging by MALDI-Ion mobility mass spectrometry. J. Am. Soc. Mass Spectrom. 21(3), 338-347 (2010
32. Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 8(18), 3715-3724 (2008
33. Hammarlund-Udenaes M. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations? Basic Clin. Pharmacol. Toxicol. 106(3), 215-220 (2010
34. Summerfield S, Dong K. In vitro, in vivo and in silico models of drug distribution into the brain. J. Pharmacokinet. Pharmacodyn. 40(3), 301-314 (2013
35. Liu X, Ide Jl, Norton I, et al. Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci. Rep. 3, 2859 (2013
36. Rizzardi K, Wahab T, Jernberg C. Rapid subtyping of Yersinia enterocolitica by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for diagnostics and surveillance. J. Clin. Microbiol. 51(12), 4200-4203 (2013
37. Ricci C, Nyadong L, Yang F, et al. Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal. Chim. Acta 623(2), 178-186 (2008
38. Dunn JD, Gryniewicz-Ruzicka CM, Kauffman JF, Westenberger BJ, Buhse LF. Using a portable ion mobility spectrometer to screen dietary supplements for sibutramine. J. Pharm. Biomed. Anal. 54(3), 469-474 (2011
39. Mather CA, Rivera SF, Butler-Wu SM. Comparison of the bruker biotyper and vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. J. Clin. Microbiol. 52(1), 130-138 (2014
40. Pajander J, Haugshøj KB, Bjørneboe K, Wahlberg P, Rantanen J. Foreign matter identification from solid dosage forms. J. Pharm. Biomed. Anal. 80(0), 116-125 (2013
41. Leuthold LA, Mandscheff J-F, Fathi M, et al. Desorption electrospray ionization mass spectrometry: direct toxicological screening and analysis of illicit Ecstasy tablets. Rapid Commun. Mass Spectrom. 20(2), 103-110 (2006
42. Attygalle AB, Jariwala FB, Pavlov J, Yang Z, Mahr JA, Oviedo M. Direct detection and identification of active pharmaceutical ingredients in intact tablets by helium plasma ionization (HePI) mass spectrometry. J. Pharmaceut. Anal. 4(3), 166-172 (2014
43. Morelato M, Beavis A, Kirkbride P, Roux C. Forensic applications of desorption electrospray ionisation mass spectrometry (DESI-MS). Forensic Sci. Int. 226(1-3), 10-21 (2013